SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences informs about disclosure

05 Jun 2025 Evaluate
With reference to earlier letters dated 14th May, 2025, 28th May, 2025 and 04th June, 2025 regarding the Extra-Ordinary General Meeting (EGM) of the Company held today Thursday, 05th June, 2025 and the business mentioned in Notice dated 13th May, 2025 was transacted, Suven Life Sciences has informed that it enclosed the following: Summary of proceedings as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I; The Report of Scrutinizer on remote e-voting and voting at EGM (by electronic means) as Annexure- II.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

194.65 16.35 (9.17%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×